Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

RenovoRx, Inc. - Common Stock (NQ:RNXT)

0.8505 +0.0078 (+0.93%)
Streaming Delayed Price Updated: 11:21 AM EST, Dec 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about RenovoRx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
63 Biggest Movers From Yesterday ↗
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire. Global Internet... 
Via Benzinga
News headline image
34 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 37.7% to $4.64. Emclaire Financial Corp (NASDAQ: EMCF) shares climbed 32.8% to $38.35 after the company and... 
Via Benzinga
News headline image
58 Biggest Movers From Yesterday ↗
Gainers Allego N.V. (NYSE: ALLG) shares surged 114.1% to close at $17.73 on Wednesday after the company announced the completion of its merger agreement with Spartan Acquisition... 
Via Benzinga
News headline image
RenovoRx Enrolls First Pancreatic Cancer Patient at Columbia University’s New York-Presbyterian Hospital Irving Medical Center in Ongoing TIGeR-PaC Phase 3 Clinical Trial
From RenovoRx, Inc.
Via Business Wire
News headline image
23 Stocks Moving in Friday's Pre-Market Session ↗
Gainers Modular Medical Inc (NASDAQ: MODD) rose 321% to $15.64 in pre-market trading. Modular Medical, on Thursday, reported pricing of $15 million public offering... 
Via Benzinga
News headline image
RenovoRx to Host “Delivering Therapy Where it Matters” Fireside Chat with CEO, Shaun Bagai, on February 23rd at 12 P.M. ET
From RenovoRx, Inc.
Via Business Wire
News headline image
RenovoRx Announces Presentation at the 2022 SPECTRUM Conference Highlighting Its Innovative RenovoTAMP™ Therapy for Targeted Treatment of Cancer
From RenovoRx, Inc.
Via Business Wire
News headline image
RenovoRx to Present at the H.C. Wainwright Bioconnect Virtual Conference
From RenovoRx, Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a... 
Via Benzinga
News headline image
5 Short Squeeze Candidates To Watch: Pioneer Power, NuZee Remain At The Top, Grab Rejoins The Leaderboard ↗
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYS... 
Via Benzinga
News headline image
Short Squeeze Stocks: PPSI, NUZE and 3 Others Experts Think Are Ready to Pop ↗
PPSI, NUZE, and three other stocks are ranked highly in Fintel's Short Squeeze Screener. All three names have a score higher than 96. 
Via InvestorPlace
News headline image
5 Short Squeeze Candidates To Watch: Pioneer Power Tops List Along With Newegg, Nuzee And More ↗
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE: GME) and AMC Entertainment Holdings (NYSE: AMC... 
Via Benzinga
News headline image
RenovoRx Announces Third Quarter 2021 Financial Results
From RenovoRx
Via Business Wire
News headline image
RenovoRx Announces Presentation of Final Data from RR2 Observational Registry Study at 2021 Pancreas Club Annual Meeting
From RenovoRx, Inc.
Via Business Wire
News headline image
76 Biggest Movers From Yesterday ↗
Gainers Expensify, Inc. (NASDAQ: EXFY) jumped 52.1% to settle at $41.06 on Wednesday after the company priced its IPO at $27 per share. RenovoRx, Inc. (NASDAQ: RNXT) shares... 
Via Benzinga
Topics Initial Public Offering
News headline image
Mid-Afternoon Market Update: Nasdaq Tumbles 300 Points; PubMatic Shares Gain After Q3 Results ↗
Toward the end of trading Wednesday, the Dow traded down 0.67% to 36,075.12 while the NASDAQ fell 1.90% to 15,585.20. The S&P also fell, dropping 0.99% to 4,638.64. The U.S.... 
Via Benzinga
Topics Stocks
News headline image
Dear FSR Stock Fans, Mark Your Calendars for an EV Catalyst on Nov. 17 ↗
Fisker (FSR) investors are going to want to keep an eye on FSR stock when Nov. 17 rolls around next Wednesday for a big reveal. 
Via InvestorPlace
Topics Electric Vehicles
News headline image
RNXT Stock Alert: 5 Things to Know as RenovoRx Soars 100+% Today ↗
RenovoRx (RNXT) stock is rocketing higher today thanks to a presentation of data at a medical conference yesterday evening. 
Via InvestorPlace
News headline image
Mid-Morning Market Update: Markets Edge Lower; US Inflation Rate Increases To 6.2% ↗
Following the market opening Wednesday, the Dow traded down 0.07% to 36,293.80 while the NASDAQ fell 0.23% to 15,850.04. The S&P also fell, dropping 0.05% to 4,682.75. The U.S... 
Via Benzinga
Topics Stocks
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Good morning, trader! It's time to start another busy day of trading with a dive into the biggest pre-market stock movers for Wednesday. 
Via InvestorPlace
News headline image
30 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers RenovoRx, Inc. (NASDAQ: RNXT) rose 113% to $11.50 in pre-market trading. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a... 
Via Benzinga
News headline image
Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic Cancer
From RenovoRx, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2021 ↗
Upgrades According to TD Securities, the prior rating for Thomson Reuters Corp (NYSE: 
Via Benzinga
News headline image
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
Via Benzinga
InvestorNewsBreaks – RenovoRx Inc. (NASDAQ: RNXT) Closes $16.7M IPO
Via Investor Brand Network
News headline image
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
Via Benzinga
News headline image
72 Biggest Movers From Yesterday ↗
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.